Hewmun Lau
InvestorPrincipal at Broadview Ventures
Boston, Massachusetts
Writes $100K β $5M checks Β· typically $1.5M
About
Principal on the Biopharma team involved in day-to-day investment activities. Brings 15 years in life sciences with prior roles at Merrimack Pharmaceuticals and Navigant Consulting.
Experience
- Broadview Ventures IncPrincipalcurrent2019 β presentGreater Boston
- Longview VenturesPrincipalcurrent2019 β presentBoston, Massachusetts, United States
- Mosanna TherapeuticsMember Board of Directorscurrent2025 β present
- Basking BiosciencesBoard Observercurrent2020 β presentResearch Triangle Park, North Carolina
- Antag TherapeuticsBoard Observer2020 β 2024Copenhagen, Denmark
- RenovacorBoard Observer2020 β 2021Philadelphia, Pennsylvania
- MerrimackDirector of Corporate Development2018 β 2019Cambridge, MA
- MerrimackAssociate Director, New Product Planning and Business Development2017 β 2018Cambridge, MA
- MerrimackSenior Manager, Commercial Analytics - ONIVYDE2015 β 2017Cambridge, MA
- NavigantSenior Consultant (Life Sciences Practice)2012 β 2015Greater Boston
- NavigantSummer Associate (Life Sciences Practice)2011Boston, MA
- RXi Pharmaceuticals CorpSummer Intern2010Worcester, MA
- McLean HospitalResearch Associate2007 β 2009
- Millennium PharmaceuticalsResearch Assistant2006 β 2007Cambridge, MA
Education
- MIT Sloan School of ManagementMBA
- Brandeis UniversityBiochemistry, Biology and Economics
- Harvard-MIT Division of Health Sciences and TechnologyMS, Biomedical Enterprise
Skills & more
InvestmentsStrategic PlanningCardiovascular DiseaseLifesciences11Genetics4Data Analysis6Business Strategy4Drug Discovery7Financial Modeling3Life Sciences2Clinical Trials3Laboratory2
+4 more
Management ConsultingBusiness DevelopmentBiotechnologyStrategyLanguages Bahasa Malaysia Β· Cantonese Β· Mandarin
From Hewmun's professional profile.
Same school
Also attended MIT Sloan School of Management427
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor
+ 421 more
Also attended Brandeis University57
Santiago ReganDirector of Business Development at Redpoint VenturesNicholas AdamsManaging Partner at Differential VenturesJohn KeiltyVenture Partner at Third Rock VenturesKevin GillisPartner and Chief Operating Officer at Third Rock VenturesSeth LieblichInvestment Team at 8VCAlex MorganInvestor at Khosla Ventures
+ 51 more
Shared employers
Also worked at Longview Ventures8
Christopher de SouzaDirector at Broadview VenturesBenjamin KreitmanPrincipal at Broadview VenturesThomas NeedhamDirector, Head of the Biopharma Practice at Broadview VenturesDaniel GottliebDirector at Broadview VenturesDavid PrimPrincipal at Broadview VenturesMaria BerkmanPartner at Vensana Capital
+ 2 more
Also worked at Antag Therapeutics4
Also worked at Merrimack2
Also worked at Navigant19
Kate WilschutzChief Financial Officer, Revolution Funds at RevolutionMaggie RodneyPartner at MassiveChristina HangSr. Research Analyst at Sands Capital VenturesKrishna ShahSenior Associate at CVS Health VenturesBatul JoffreyPrincipal at Kapor CapitalAustin MartinVice President at Optum Ventures
+ 13 more
Colleagues at Broadview Ventures
Annabel Chen-Tournoux
Investor at Broadview Ventures
Anubodh Sunny Varshney
Venture Advisor at Broadview Ventures
Benjamin Kreitman
Principal at Broadview Ventures
Christopher Colecchi
Managing Director at Broadview Ventures
Christopher de Souza
Director at Broadview Ventures
Daniel Gottlieb
Director at Broadview Ventures
David Milan
Chief Scientific Officer, Leducq Corp at Broadview Ventures
David Prim
Principal at Broadview Ventures






























